MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s13104-017-3086-7

Медицинская библиотека · BMC research notes · 2017

Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs.

Tawaratsumida Hiroki, Setoguchi Takao, Arishima Yoshiya, Ohtsubo Hideo, Akimoto Masaki, Ishidou Yasuhiro, Nagano Satoshi, Taketomi Eiji, Sunahara Nobuhiko, Komiya Setsuro

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Osteoporosis is a complication of rheumatoid arthritis. We examined the risk factors for bone loss in rheumatoid arthritis patients receiving biological disease-modifying anti-rheumatic drugs. Lumbar spine and femoral neck bone mineral density was measured at two time points in 153 patients with rheumatoid arthritis managed with biological disease-modifying anti-rheumatic drugs. We examined patients' variables to identify risk factors for least significant reduction of bone mineral density.

RESULTS

Least significant reduction of lumbar spine bone mineral density (≤ - 2.4%) was seen in 13.1% of patients. Least significant reduction of femoral neck bone mineral density (≤ - 1.9%) was seen in 34.0% of patients. Multiple logistic regression analysis showed that a risk factor for least significant reduction of the lumbar spine was high-dose methylprednisolone use. Multiple regression analysis showed that a risk factor for least significant reduction of the femoral neck was short disease duration. Our findings showed that a risk factor for femoral neck bone mineral density reduction was a short disease duration. These findings suggest that rheumatoid arthritis patients receiving treatment with biological disease-modifying anti-rheumatic drugs may benefit from earlier osteoporosis treatments to prevent femoral neck bone loss.

Для цитирования: Tawaratsumida Hiroki, Setoguchi Takao, Arishima Yoshiya, Ohtsubo Hideo, Akimoto Masaki, Ishidou Yasuhiro, Nagano Satoshi, Taketomi Eiji, Sunahara Nobuhiko, Komiya Setsuro. Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs.. BMC research notes. 2017. DOI: 10.1186/s13104-017-3086-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.